Oct 19, 2017
Though opioid abuse is clearly an issue for cancer patients post-surgery, many other potential factors were not accounted for and should be included in a more in-depth study that goes beyond database analysis.
Related Arcticle: New Persistent Opioid Use Among Patients With Cancer After Curative-Intent...
Oct 12, 2017
The paper examines the cost-effectiveness of schedules of bone-modifying agents in patients with breast cancer and skeletal metastases and supports the 3-month administration of the generic zoledronic acid in terms of cost and efficacy.